Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,338 | 3 | 68.1% |
| Travel and Lodging | $1,030 | 9 | 11.1% |
| Food and Beverage | $830.50 | 11 | 8.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $750.00 | 2 | 8.1% |
| Honoraria | $360.00 | 1 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,549 | 2 | $0 (2019) |
| Cardinal Health 414, LLC | $2,461 | 10 | $0 (2017) |
| R-Pharm US LLC | $1,398 | 3 | $0 (2019) |
| GENZYME CORPORATION | $880.05 | 3 | $0 (2024) |
| Athenex Pharmaceutical Division, LLC | $392.23 | 3 | $0 (2019) |
| Daiichi Sankyo Inc. | $360.00 | 1 | $0 (2023) |
| UCB, Inc. | $116.46 | 1 | $0 (2017) |
| Covidien LP | $74.48 | 1 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $45.00 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $32.40 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.05 | 1 | GENZYME CORPORATION ($130.05) |
| 2023 | $360.00 | 1 | Daiichi Sankyo Inc. ($360.00) |
| 2021 | $375.00 | 1 | GENZYME CORPORATION ($375.00) |
| 2019 | $5,615 | 8 | AstraZeneca Pharmaceuticals LP ($3,450) |
| 2018 | $250.67 | 4 | AstraZeneca Pharmaceuticals LP ($98.79) |
| 2017 | $2,577 | 11 | Cardinal Health 414, LLC ($2,461) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2024 | GENZYME CORPORATION | CEREZYME (Biological) | Food and Beverage | In-kind items and services | $130.05 | General |
| Category: Genetic Disease | ||||||
| 12/04/2023 | Daiichi Sankyo Inc. | — | Honoraria | Cash or cash equivalent | $360.00 | General |
| 12/21/2021 | GENZYME CORPORATION | ALPROLIX (Biological), ELOCTATE | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: Hematology | ||||||
| 11/25/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| 10/24/2019 | R-Pharm US LLC | Ixempra (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Oncology | ||||||
| 10/24/2019 | R-Pharm US LLC | Ixempra (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
| 10/24/2019 | R-Pharm US LLC | Ixempra (Drug) | Travel and Lodging | Cash or cash equivalent | $73.00 | General |
| Category: Oncology | ||||||
| 05/13/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $3,450.00 | General |
| Category: Oncology | ||||||
| 04/26/2019 | Athenex Pharmaceutical Division, LLC | Oraxol (Drug) | Travel and Lodging | In-kind items and services | $228.00 | General |
| Category: Breast Cancer | ||||||
| 04/26/2019 | Athenex Pharmaceutical Division, LLC | Oraxol (Drug) | Travel and Lodging | In-kind items and services | $114.23 | General |
| Category: Breast Cancer | ||||||
| 04/26/2019 | Athenex Pharmaceutical Division, LLC | Oraxol (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Breast Cancer | ||||||
| 11/10/2018 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 11/10/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $32.40 | General |
| Category: Oncology | ||||||
| 09/27/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $98.79 | General |
| Category: Oncology | ||||||
| 06/29/2018 | Covidien LP | Barrx (Device) | Food and Beverage | In-kind items and services | $74.48 | General |
| Category: GI Solutions | ||||||
| 11/01/2017 | Cardinal Health 414, LLC | — | Travel and Lodging | Cash or cash equivalent | $34.00 | General |
| 11/01/2017 | Cardinal Health 414, LLC | — | Travel and Lodging | Cash or cash equivalent | $9.00 | General |
| 11/01/2017 | Cardinal Health 414, LLC | — | Travel and Lodging | Cash or cash equivalent | $7.00 | General |
| 10/18/2017 | Cardinal Health 414, LLC | — | Consulting Fee | Cash or cash equivalent | $1,687.50 | General |
| 09/30/2017 | Cardinal Health 414, LLC | — | Food and Beverage | In-kind items and services | $48.71 | General |
| 09/30/2017 | Cardinal Health 414, LLC | — | Food and Beverage | In-kind items and services | $46.01 | General |
| 09/29/2017 | Cardinal Health 414, LLC | — | Travel and Lodging | In-kind items and services | $352.40 | General |
| 09/29/2017 | Cardinal Health 414, LLC | — | Travel and Lodging | In-kind items and services | $155.60 | General |
| 09/29/2017 | Cardinal Health 414, LLC | — | Food and Beverage | In-kind items and services | $63.60 | General |
| 09/29/2017 | Cardinal Health 414, LLC | — | Travel and Lodging | In-kind items and services | $56.75 | General |
About Dr. Allen Korenblit, M.D
Dr. Allen Korenblit, M.D is a Pediatric Hematology-Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851322929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allen Korenblit, M.D has received a total of $9,308 in payments from pharmaceutical and medical device companies, with $130.05 received in 2024. These payments were reported across 26 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($6,338).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Chicago, IL
- Active Since 07/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1851322929
Products in Payments
- LYNPARZA (Drug) $3,450
- Ixempra (Drug) $1,398
- Oraxol (Drug) $392.23
- ALPROLIX (Biological) $375.00
- NO PRODUCT DISCUSSED (Drug) $375.00
- CEREZYME (Biological) $130.05
- Briviact (Drug) $116.46
- IMFINZI (Drug) $98.79
- Barrx (Device) $74.48
- OPDIVO (Biological) $32.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Chicago
Alexis Thompson, Md, MD
Pediatric Hematology-Oncology — Payments: $1.6M
James Labelle
Pediatric Hematology-Oncology — Payments: $249,251
Sherif Badawy, Md, MD
Pediatric Hematology-Oncology — Payments: $207,866
Dr. Loretta Li, M.d, M.D
Pediatric Hematology-Oncology — Payments: $187,559
Susan Cohn
Pediatric Hematology-Oncology — Payments: $125,685
Leonard Valentino, M.d, M.D
Pediatric Hematology-Oncology — Payments: $117,453